Tower Research Capital LLC (Trc) Rapt Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,289 shares of RAPT stock, worth $5,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,289

Previous 10,758 50.84%

Holding current value

$5,659

Previous $32,000 68.75%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.76 - $3.75 $9,625 - $20,508	-5,469 Reduced 50.84%	5,289 $10,000
Q2 2024 Aug 13, 2024	BUY	$2.89 - $9.38 $19,432 - $63,071	6,724 Added 166.68%	10,758 $32,000
Q1 2024 May 15, 2024	SELL	$6.87 - $26.45 $41,556 - $159,996	-6,049 Reduced 59.99%	4,034 $36,000
Q4 2023 Feb 13, 2024	BUY	$11.28 - $25.46 $105,118 - $237,261	9,319 Added 1219.76%	10,083 $250,000
Q3 2023 Nov 14, 2023	SELL	$16.34 - $24.66 $36,438 - $54,991	-2,230 Reduced 74.48%	764 $12,000
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $15,305 - $20,594	953 Added 46.69%	2,994 $55,000
Q1 2023 May 09, 2023	SELL	$17.19 - $30.8 $66,783 - $119,658	-3,885 Reduced 65.56%	2,041 $37,000
Q4 2022 Feb 10, 2023	SELL	$16.28 - $24.6 $17,045 - $25,756	-1,047 Reduced 15.02%	5,926 $118,000
Q3 2022 Nov 10, 2022	BUY	$17.96 - $30.46 $102,102 - $173,165	5,685 Added 441.38%	6,973 $168,000
Q2 2022 Aug 15, 2022	SELL	$10.26 - $23.59 $3,960 - $9,105	-386 Reduced 23.06%	1,288 $23,000
Q1 2022 May 12, 2022	SELL	$17.02 - $40.22 $28,338 - $66,966	-1,665 Reduced 49.87%	1,674 $37,000
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $60,327 - $80,777	2,045 Added 158.04%	3,339 $123,000
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $5,792 - $7,657	194 Added 17.64%	1,294 $40,000
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $8,455 - $18,809	-470 Reduced 29.94%	1,100 $35,000
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $16,448 - $25,144	-1,028 Reduced 39.57%	1,570 $35,000
Q4 2020 Feb 16, 2021	SELL	$15.89 - $40.87 $110,530 - $284,291	-6,956 Reduced 72.81%	2,598 $51,000
Q3 2020 Nov 16, 2020	BUY	$21.6 - $37.5 $185,522 - $322,087	8,589 Added 890.05%	9,554 $308,000
Q2 2020 Aug 13, 2020	BUY	$14.16 - $32.85 $13,664 - $31,700	965 New	965 $28,000
Q1 2020 May 15, 2020	SELL	$11.86 - $48.86 $11,077 - $45,635	-934 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$12.3 - $30.78 $11,488 - $28,748	934 New	934 $26,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $31.7M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Rapt Therapeutics, Inc. Transaction History